LONDON--(BUSINESS WIRE)--Regulatory News: BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, today ...
CAMBRIDGE, Mass., Jan. 4, 2018 /PRNewswire/ -- Sigilon Therapeutics, a biopharmaceutical company that discovers and develops immune-privileged Living Therapeutics, today announced the appointment of ...
BenevolentAI CEO Dr Joerg Moeller tells Proactive's Stephen Gunnion how the company is positioning itself as a pioneer in AI-augmented drug discovery, aiming to enhance the success rates of drug ...
Toulouse, France, November 7, 2013 - Genticel, a biopharmaceutical company that develops innovative vaccines for patients infected with the human papillomavirus (HPV), has appointed a new ...
AYOXXA Biosystems GmbH has announced that Dr. Gerald Möller has joined the company's supervisory board as an independent board director and chairman of the board. With 40 years of experience in Pharma ...
Moller Industries, the brainchild of inventor Dr. Paul Moller, announced recently that production would begin on the company's M200G volantor, a UFO-esque hovercraft that apparently can "glide over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback